Søgeresultater - Kivitz, Alan
- Showing 1 - 20 results of 68
- Go to Next Page
-
1
-
2
A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolon... af Kivitz, Alan, Kwong, Louis, Shlotzhauer, Tammi, Lufkin, Joelle, Cinar, Amy, Kelley, Scott
Udgivet 2019Text -
3
Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA) af Bingham, Clifton O, Rizzo, Warren, Kivitz, Alan, Hassanali, Azra, Upmanyu, Ruchi, Klearman, Micki
Udgivet 2015Text -
4
Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinic... af Kivitz, Alan J., Conaghan, Philip G., Cinar, Amy, Lufkin, Joelle, Kelley, Scott D.
Udgivet 2019Text -
5
Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension Study af Kivitz, Alan, Wallace, Thomas, Olech, Ewa, Borofsky, Michael, Devenport, Jenny, Pei, Jinglan, Michalska, Margaret
Udgivet 2016Text -
6
-
7
-
8
A Randomized, Open-Label, Single-Dose Study to Assess Safety and Systemic Exposure of Triamcinolone Acetonide Extended-Release in Patients With Hip Osteoarthritis af Kivitz, Alan, Mehra, Purvi, Hanson, Peter, Kwong, Louis, Cinar, Amy, Lufkin, Joelle, Kelley, Scott
Udgivet 2022Text -
9
Safety and Systemic Exposure of Triamcinolone Acetonide Following Ultrasound-Guided Intra-Articular Injection of Triamcinolone Extended-Release or Standard Triamcinolone Acetonide... af Hanson, Peter, Kivitz, Alan, Mehra, Purvi, Kwong, Louis, Cinar, Amy, Lufkin, Joelle, Kelley, Scott D.
Udgivet 2021Text -
10
-
11
Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid Arthritis af Kivitz, Alan, Baret-Cormel, Lydie, van Hoogstraten, Hubert, Wang, Sheldon, Parrino, Janie, Xu, Christine, Stanislav, Marina
Udgivet 2017Text -
12
-
13
Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials af Kivitz, Alan J., FitzGerald, Oliver, Nash, Peter, Pang, Shirley, Azevedo, Valderilio F., Wang, Cunshan, Takiya, Liza
Udgivet 2021Text -
14
Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized contro... af Bickham, Kara, Kivitz, Alan J., Mehta, Anish, Frontera, Nancy, Shah, Sandhya, Stryszak, Paul, Popmihajlov, Zoran, Peloso, Paul M.
Udgivet 2016Text -
15
Single-Arm Study of Etanercept in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment af Bessette, Louis, Khraishi, Majed, Kivitz, Alan J., Kaliyaperumal, Arunan, Grantab, Rama, Poulin-Costello, Melanie, Isaila, Maya, Collier, David
Udgivet 2017Text -
16
Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2 af Marzo-Ortega, Helena, Sieper, Joachim, Kivitz, Alan, Blanco, Ricardo, Cohen, Martin, Delicha, Evie-Maria, Rohrer, Susanne, Richards, Hanno
Udgivet 2017Text -
17
Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study af Kivitz, Alan J., Wagner, Ulf, Dokoupilova, Eva, Supronik, Jerzy, Martin, Ruvie, Talloczy, Zsolt, Richards, Hanno B., Porter, Brian
Udgivet 2018Text -
18
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis af Cohen, Stanley, Pablos, Jose L., Pavelka, Karel, Müller, Gerard Anton, Matsumoto, Alan, Kivitz, Alan, Wang, Hui, Krishnan, Eswar
Udgivet 2019Text -
19
Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgrou... af Berenbaum, Francis, Schnitzer, Thomas, Kivitz, Alan, Viktrup, Lars, Johnston, Elizabeth, Yang, Ruoyong, Whalen, Ed, Tive, Leslie, Semel, David
Udgivet 2021Text -
20
A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol af Curtis, Jeffrey R., Churchill, Melvin, Kivitz, Alan, Samad, Ahmed, Gauer, Laura, Gervitz, Leon, Koetse, Willem, Melin, Jeffrey, Yazici, Yusuf
Udgivet 2015Text